Groups Continue To Warn TPP Could Harm Access To Medicines As U.S. Senate Votes To Deny Debate On Fast-Track Legislation
GlobalPost: This U.S.-backed Pacific trade deal could stop the poor from getting life-saving meds
“…[H]undreds of millions of patients around the Pacific rim face losing the chance to use new, cheap generic drugs to treat a host of conditions, including cancer, multiple sclerosis, Alzheimer’s, and rheumatoid arthritis. That’s thanks to the Trans-Pacific Partnership, or TPP, a Washington-backed mega-trade agreement that would include Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States, and Vietnam…” (Grillo/Tegel, 5/12).
International Business Times: Trans-Pacific Partnership Health And Medicine Policies Could Hurt Poor Nations, Boost Pharmaceutical Companies
“Health organizations across the globe have taken a strong stance against the Trans-Pacific Partnership trade deal, saying it would shoot up drug costs and hurt people in poorer countries. The controversial deal is up for a vote in the Senate on Tuesday to allow President Barack Obama fast track authority in negotiating the deal…” (Marcin, 5/12).
Wall Street Journal: Senate Democrats Block Debate on Obama’s Fast-Track Bill
“Senate Democrats derailed a top White House economic priority Tuesday, blocking a bill to give President Barack Obama authority to ease trade deals through Congress and forcing the administration and Republican leaders to regroup on trade policy. … The Senate action almost certainly won’t be the last word on advancing trade deals, since a majority of senators are believed to favor both the fast-track measure and the Trans-Pacific Partnership, the big trade deal between the U.S. and 11 nations around the Pacific whose path would be eased by the fast-track legislation. Late Tuesday, Democrats had already proposed a way to bridge the divide…” (Hughes/Mauldin, 5/12).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.